Abstract
Two distinct patterns of immune recovery inflammatory syndrome (IRIS) are recognized, paradoxical and unmasking IRIS. Here we raise some concerns regarding the first case of neuroPCM-IRIS published to date, as recently proposed by Almeida and Roza (Mycopathologia 177:137–141, 2017) for a patient originally described by Silva-Vergara et al. (Mycopathologia 182:393–396, 2014), taking in account the different case definitions for IRIS and the cases of neuroparacoccidioidomycosis already described in the literature. We are concerned that data from the case report have been misinterpreted and that no regard has been given to the possibility that the development of manifestations of neuroPCM after starting antiretroviral therapy and antifungal treatments could represent the predicted course of a missed neuroPCM diagnosis at presentation whose treatment failed. We hypothesize that diagnosis of the neuroPCM would not have been missed if careful screening for opportunistic infection of the central nervous system was performed prior to antiretroviral therapy initiation. Currently, there is no definitive diagnostic test for IRIS and diagnostic suspicion, as well as its management, are based on image studies and non-specific clinical signs and symptoms of inflammation. IRIS remains a diagnosis of exclusion, after considering drug toxicity, microbiologic treatment failure and the expected course of newly or previously diagnosed opportunistic infections.
Similar content being viewed by others
References
French MA. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis. 2009;48:101–7.
Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis. 2007;7:395–401.
Haddow LJ, Colebunders R, Meintjes G, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV infected individual: proposed clinical case definitions. Lancet Infect Dis. 2010;10:791–802.
Silva-Vergara ML, Rocha IH, Vasconcelos RR, et al. Central nervous system paracoccidioidomycosis in an AIDS patient: case report. Mycopathologia. 2014;177:137–41.
de Almeida SM, Roza TH. HIV immune recovery inflammatory syndrome and central nervous system paracoccidiodomycosis. Mycopathologia. 2017;182:393–6.
French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS. 2004;18:1615–27.
Shelburne ISA, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine. 2002;81:213–27.
Robertson J, Meier M, Wall J, et al. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis. 2006;42:1639–46.
de Almeida SM, Queiroz-Telles F, Teive HA, et al. Central nervous system paracoccidioidomycosis: clinical features and laboratorial findings. J Infect. 2004;48:193–8.
Shikanai-Yasuda MA, Mendes RP, Colombo AL, et al. Brazilian guidelines for the clinical management of paracoccidioidomycosis. Rev Soc Bras Med Trop. 2017;. https://doi.org/10.1590/0037-8682-0383-2017.
Ma Q, Okusanya OO, Smith PF, et al. Pharmacokinetic drug interactions with nonnucleoside reverse transcriptase inhibitors. Expert Opin Drug Metab Toxicol. 2005;1:473–85.
Walker NF, Scriven J, Meintjes G, et al. Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV AIDS. 2015;7:49–64.
Davies MA, Meintjes G. Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs. Clin Infect Dis. 2009;49:973–5.
Morejón KM, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case-control study. Am J Trop Med Hyg. 2009;80:359–66.
Hutzler RU, Brussi MLP, Capitani CM, et al. Acometimento neurológico da paracoccidioidomicose avaliado pela tomografia computadorizada de crânio [in Portuguese]. Rev Paul Med. 1985;103:243–4.
Gasparetto EL, Liu CB, de Carvalho Neto A, et al. Central nervous system paracoccidioidomycosis: imaging findings in 17 cases. J Comput Assist Tomogr. 2003;27:12–7.
Pedroso VS, Vilela Mde C, Pedroso ER, et al. Paracoccidioidomycosis compromising the central nervous system: a systematic review of the literature [in Portuguese]. Rev Soc Bras Med Trop. 2009;42:691–7.
de Almeida SM, Roza TH, Salvador GLO, et al. Neurological and multiple organ involvement due to Paracoccidioides brasiliensis and HIV co-infection diagnosed at autopsy. J Neurovirol. 2017;. https://doi.org/10.1007/s13365-017-0577-1.
Finamor LP, Muccioli C, Martins MC, et al. Ocular and central nervous system paracoccidioidomycosis in a pregnant woman with acquired immunodeficiency syndrome. Am J Ophthalmol. 2002;134:456–9.
Guimarães JCA, Bortoliero AI, Bonametti AM, et al. Infecção oportunista do sistema nervoso central por Paracoccidioides brasiliensis: relato do caso [abstract no 114]. Rev Soc Bras Med Trop. 1991;24:30–1.
Colombo AL, Junior GT, Lotfi CJ et al. Paracoccidioidomicose disseminada em pacientes com AIDS (achado de necropsia) [abstract no 42]. In: Program and abstracts of the 26th congresso da sociedade Brasileira de medicina tropical (São Paulo). São Paulo: Sociedade Brasileira de Medicina Tropical; 1989.
Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8:516–23.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Standards
There was no research involving human participants or animals.
Rights and permissions
About this article
Cite this article
Buccheri, R., Benard, G. Opinion: Paracoccidioidomycosis and HIV Immune Recovery Inflammatory Syndrome. Mycopathologia 183, 495–498 (2018). https://doi.org/10.1007/s11046-017-0230-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-017-0230-9